Annals of Hematology

Article	Citations
Composite diffuse large B-cell and peripheral T-cell lymphoma with T-helper phenotype treated with both rituximab and brentuximab vedotin	62
Telomere shortening in donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation: a case report	53
Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria	50
Total marrow irradiation as part of autologous stem cell transplantation for patients with multiple myeloma	49
Income and education affect prognosis and treatment in symptomatic myeloma	43
The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma	41
Comparison of ATG-thymoglobulin with atg-fresenius in patients with hematological malignancies who undergo allogeneic hematopoietic stem cell transplantation: a propensity score-matched analysis	38
Tumor microenvironment as a novel therapeutic target for lymphoid leukemias	37
Visual presentation of age differences in relative survival of hematological neoplasms in Sweden and the neighboring countries	36
Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia	36
TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy	35
The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma	35
High susceptibility of febrile neutropenia in Japanese patients receiving venetoclax plus azacitidine therapy for acute myeloid leukemia	34
Extramedullary and extranodal manifestations in chronic lymphocytic leukemia – an update	33
CMV infection is a risk factor for hemorrhagic cystitis after hematopoietic stem cell transplantation	29
Generic ibrutinib a potential cost-effective strategy for the first-line treatment of chronic lymphocytic leukaemia	29
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration	28
Characteristics, outcomes and treatment patterns in acute myeloid leukemia patients 60 years or older in Colombia: a RENEHOC-PETHEMA study	27
Ruxolitinib for pediatric acute and chronic graft-versus-host disease: a single-center retrospective study of efficacy and safety	26
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations	25
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study	25
Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis	24
COVID-19 outcomes among patients with sickle cell disease or sickle cell trait compared to the general population: a systematic review and meta-analyses	23
Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximab	23
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis	22

Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis	21
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015	21
Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation	20
Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005–2016	20
A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin–based IST in Chinese patients with severe aplastic anemia	20
The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis	20
Efficacy and safety of selinexor-based regimens for relapsed/refractory multiple myeloma: a systematic review of literature	19
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma	19
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients	19
The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease	19
Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience	18
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis	18
NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia	18
Inherited transmission of the CSF3R T618I mutation: a familial report	18
Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma	17
Pyrexia of unknown origin—a rare presentation of disseminated leprosy in the bone marrow	17
The role of TMPRSS6 gene polymorphism in iron resistance iron deficiency anaemia (IRIDA): a systematic review	17
Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement	16
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic leukemia–like chemotherapy	16
A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia	16
Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia	16
Heme oxygenase 1 in erythropoiesis: an important regulator beyond catalyzing heme catabolism	16
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group	15
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis	15
Severe aplastic anemia with acquired X chromosome clonality as a sole abnormality	14
A study of the relationship between circulating cytokines (interleukin-2 receptor and tumor necrosis factor receptor 2) and risk of B-cell non-hodgkin lymphoma	14
Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome	14
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients	14
Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia	14
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensi	14
Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis	14
Screening for hereditary spherocytosis in daily practice: what is the best algorithm using erythrocyte and reticulocyte parameters?	14
An adult case of systemic lupus erythematosus and cerebral vasculitis after umbilical cord blood transplantation for acute myeloid leukemia	13
Prognostic value of hyperlactatemia and lactate clearance in septic patients with hematological malignancies	13
Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia	13
Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data	13
Treatment-related leukoencephalopathy in adults with central nervous system lymphoma: a retrospective analysis of 126 patients	13
Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriers	13
The life threat in hematopoietic allogeneic stem cell transplantation - an interview and focus group study on health care professionals’ perspectives	13
T-cell lymphoma associated with dupilumab	13
GP1BB c.179C > T is the most frequent cause of monoallelic Bernard–Soulier syndrome in the Italian population after the Bolzano variant: a report of two new families	12
Can we restart the rituximab after remission of rituximab-induced interstitial lung disease in malignant lymphoma?	12
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials	12
Risk factors and a prediction model of severe asparaginase-associated pancreatitis in children	12
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts	12
Disseminated Mycobacterium haemophilum infection during alemtuzumab treatment of T-cell prolymphocytic leukemia	11
Very severe aplastic anemia with papillary thyroid carcinoma: treatment with allo-HSCT—a case report and literature review	11
To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a	11
A multicentre trial of intensive immunosuppressive therapy combined with umbilical cord blood for the treatment of severe aplastic anaemia	11
Advances in the ocular complications after hematopoietic stem cell transplantation	11

Real world outcomes of lenalidomide or bortezomib maintenance in patients with multiple myeloma not undergoing stem cell transplantation	11
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy	11
Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients	11
Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments	11
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis	11
Inherited macrothrombocytopenia due to a novel splice donor site mutation in ITGB3	11
Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report	11
Aspergillus pericardial empyema successfully treated with percutaneous drainage in a patient with invasive pulmonary aspergillosis	11
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension	11
Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience	11
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis	11
Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma	11
Comment on: Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis	11
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia	10
Differentiation syndrome and coagulation disorder — comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemia	10
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study	10
Impact of different CEBPA mutations on therapeutic outcome in acute myeloid leukemia	10
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma	10
High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China	10
Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database	10
Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients	10
Heyde syndrome	10
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version	10
R2-ISS staging combined with circulating plasma cells improves risk stratification for newly diagnosed multiple myeloma: a single-center real-world study	10
The prognostic value of controlling nutritional status (CONUT) score–based nomogram on extranodal natural killer/T cell lymphoma patients	10
Efficacy and safety-related factors of BTK inhibitors as a bridge to CAR-T therapy in R/R FL	10
Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report	10
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network)	10
Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen	10
MYC-targeted genes predict distant recurrence in patients with ocular adnexal extranodal marginal zone lymphoma	10
Highlights of ophthalmological manifestations in newly diagnosed acute leukemia: a correlation with hematological parameters	10
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects	10
Role of brentuximab vedotin plus sirolimus in the treatment of classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder: a case-based review	10
Early prediction of platelet recovery with immature platelet fraction in patients receiving hematopoietic stem cell transplantation	9
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia	9
Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL	9
Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience	9
Acute myeloid leukemia with rare recurring translocations—an overview of the entities included in the international consensus classification	9
Chronic neutropenic colitis with complete colonic obstruction in a patient with severe congenital neutropenia associated with G6PC3 mutations	9
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis	9
Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France — a cohort study using the French National Healthcare database (SNDS)	9
Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage	9
Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco	9
Stanozolol for the treatment of anemic lower-risk myelodysplastic syndromes without del(5q) after failure of epoetin alfa: findings from a retrospective study	9
Comment on: JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response	9
Improved survival of Burkitt lymphoma/leukemia patients: observations from Poland, 1999–2020	9
Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity	9
Dawn of a new era of antibody-drug conjugates and bispecific T-cell engagers for treatment of multiple myeloma: a systematic review of literature	9
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy	9
Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia	8
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis	8
Epidemiological features and a survival nomogram for primary lymphoma of the male genital tract	8
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601	8
Increased blood levels of venetoclax due to intake of crushed venetoclax tablets	8
Langerhans cell histiocytosis in adults: a retrospective, single-center case series	8
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experienc	8
COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study	8
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma	8
Relapsed mantle cell lymphoma manifesting with soft tissue tumors of the extremities: University of Miami experience and review of the literature	8
JAK2V617F mutation in patients with β-thalassemia disease: prevalence and clinical characteristics	8
Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia	8
Successful treatment of hairy cell leukemia variant with obinutuzumab	8
Presentation of two new mutations in the 3′untranslated region of the β-globin gene and evaluating the molecular spectrum of thalassemia mutations in the Mediterranean region of Turkey	8
Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease	8
Bortezomib elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells	8
Central nervous system relapse of acute promyelocytic leukemia treated by oral Venetoclax with Azacitidine achieved complete remission	8
Risk and impact of cytomegalovirus infection in lymphoma patients treated with bendamustine	8
High-flow nasal cannula oxygen in patients with haematological malignancy: a retrospective observational study	8
Olverembatinib treatment in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia	8
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzum	8
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients	8
CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase	8
A Filipino infant with severe neutropenia owing to SRP54 mutations was successfully treated with ethnically mismatched cord blood transplantation from a Japanese cord blood bank	8
Overexpression of REC8 induces aberrant gamete meiotic division and contributes to AML pathogenesis - a multiplexed microarray analysis and mendelian randomization study	8
Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia	8
Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis	7
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma	7
Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine	7
A rare case of glanzmann thrombasthenia with concomitant factor VII deficiency	7
Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study	7

Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study	7
Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation:	7
Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib	7
Transfusion of blood components in pediatric age groups: an evidence-based clinical practice guideline adapted for the use in Egypt using ‘Adapted ADAPTE’	7
The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction	7
Loeys-Dietz syndrome with concomitant aplastic anemia	7
Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysis	7
Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses	7
Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis	7
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants	7
The efficacy and safety of ZR2 versus R-CHOP-like for elderly patients with newly diagnosed diffuse large B cell lymphoma: a single-center prospective study in China	7
Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region	7
Trends in outcomes and racial disparities in adult hospitalizations for immune thrombocytopenia over a decade	7
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry	7
Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study	7
Response to Dr. Ying Cui comments	7
Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting	7
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrosp	7
Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab	7
Nomogram for predicting survival of patients with diffuse large B-cell lymphoma	7
Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6–7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor i	7
Mutations of epigenetic modifier genes predict poor outcome in adult acute lymphoblastic leukemia	7
Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL	7
Digital thermography and vascular involvement in β-thalassemia intermedia	7
Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms	7
Prevalence of and risk factors for obstructive sleep apnea in children with sickle cell: a multicentric cross sectional study	7
Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study	7
Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy	7
Novel serous effusion-related risk models and biomarkers for predicting prognosis in T-cell lymphoma patients	7
Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation	7
Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy	7
Stable responses to danicopan as add-on to ravulizumab in two patients with paroxysmal nocturnal hemoglobinuria	7
Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients	7
Peripherally inserted central venous catheters decrease central line-associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score-adjusted ana	7
Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia	7
Investigation of a hemophilia family with one female hemophilia A patient and 12 male hemophilia A patients	7
Diagnosis and management of non-clonal erythrocytosis remains challenging: a single centre clinical experience	7
Left atrial deformation indices in β-thalassemia major patients	7
Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab – case report and review of the literature	6
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia	6
A HNRNPC::RARB variant of acute promyelocytic leukemia with concurrent myeloid sarcoma of the spine	6
Genetic and clinical characteristics of primary hemophagocytic lymphohistiocytosis in children	6
Effectiveness and safety of blinatumomab for pediatric B cell acute lymphoblastic leukemia with Loeffler’s endocarditis	6
Predictors of health-related quality of life of the patients treated for MM: the first study in the Palestinian healthcare system	6
A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia	6
One disease, two faces: clonally-related AML and MPDCP with skin involvement	6
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management	6
miRNA profile and disease severity in patients with sickle cell anemia	6
Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series	6
Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma	6
Adult Langerhans cell histiocytosis with thyroid gland involvement: clinical presentation, genomic analysis, and outcome	6
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning	6
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive acute lymphoblastic leukemia	6
Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia	6
Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review	6
A new case of Bicêtre hemoglobin in an adult male: clinical observations over a period of four years	6
A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration	6
Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis	6
USF2 promotes autophagy and proliferation in chronic lymphocytic leukemia by inhibiting STUB1-induced NFAT5 ubiquitination	6
Does the order of busulfan and cyclophosphamide affect allogeneic stem cell transplantation related liver toxicity?	6
Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection	6
Mass cytometry analysis of B-cell populations in extranodal marginal-zone lymphoma of mucosa-associated lymphoid tissue of the lung	6
Pregnancy outcome in women with transfused beta-thalassemia in France	6
Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia	6
TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology, treatment challenges, and upcoming approaches	6
Interstitial lung disease presents with varying characteristics in patients with non-Hodgkin lymphoma undergoing rituximab-containing therapies	6
Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experience	6
Could it be VEXAS?	6
Predictive scoring system for distinguishing Stenotrophomonas maltophilia bacteremia from Pseudomonas aeruginosa bacteremia in patients with hematological malignancies	6
A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia	6
Venetoclax combined with decitabine and HAAG regimen: a novel salvage strategy for relapsed/refractory T-cell acute lymphoblastic leukaemia	6
Re: Arcuri and Americo “Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis”	6
Frequency, pattern, and associations of renal iron accumulation in sickle/β-thalassemia patients	6
Analysis of PROC mutations and clinical features in 22 unrelated families with inherited protein C deficiency	6
Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients	6
The role of therapeutic plasma exchange in plasma cell disorders	6
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease	6
Hematopoietic cell transplantation for MYSM1 deficiency: not so much an easy task	6
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study	6
Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate	6
Therapy-related myeloid neoplasms: a real-world pharmacovigilance analysis (1970–2023)	5
Integrated metabolomic and microbiome analysis identifies Cupriavidus metallidurans as a potential therapeutic target for β-thalassemia	5
Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities	5
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study	5
Circulating monocytes decrease significantly following disease-directed therapy and may reflect disease expansion in Langerhans Cell Histiocytosis	5
DNMT3A-R882: a mutation with many paradoxes	5
Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma	5
PEG-rhG-CSF versus rhG-CSF in supporting neutrophil recovery after induction chemotherapy for patients with newly diagnosed acute lymphoblastic leukemia	5
Correction to: Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea	5
MDS patient registries - achievements and challenges	5
Treatment outcomes between cyclosporin and chemotherapy in adult subcutaneous panniculitis-like T-cell lymphoma: a report from nation-wide Thai lymphoma study group registry	5
Prognosis of aggressive adult T-cell leukemia/lymphoma with central nervous system infiltration and utility of CD7 versus CADM1 flowcytometric plots of cerebrospinal fluid	5
Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study	5
Correction to: Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders	5
Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia	5